Phibro Animal Health Corporation (PAHC)
Price:
31.14 USD
( - -0.71 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Intra-Cellular Therapies, Inc.
VALUE SCORE:
0
2nd position
Amphastar Pharmaceuticals, Inc.
VALUE SCORE:
10
The best
Lantheus Holdings, Inc.
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.
NEWS
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results
businesswire.com
2025-08-20 16:00:00TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be availab.
PAHC vs. BSX: Which Stock Is the Better Value Option?
zacks.com
2025-08-20 12:41:23Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
zacks.com
2025-08-20 10:41:54Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?
zacks.com
2025-08-20 10:16:03Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PAHC Stock Up 76.4% in a Year: What's Driving the Rally?
zacks.com
2025-08-20 09:55:28Phibro Animal Health's 76.4% stock surge is fueled by strong sales recovery, global growth and a robust balance sheet.
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why
zacks.com
2025-08-18 13:46:16Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
zacks.com
2025-08-04 12:41:24Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?
3 Reasons Growth Investors Will Love Phibro (PAHC)
zacks.com
2025-08-01 13:46:18Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Phibro Animal Health Corporation Declares Quarterly Dividend
businesswire.com
2025-07-29 16:10:00TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner.
Best Growth Stocks to Buy for July 23rd
zacks.com
2025-07-23 10:10:22PAHC, AFYA and ROAD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 23, 2025.
Best Value Stocks to Buy for July 23rd
zacks.com
2025-07-23 10:01:52NX, OPBK and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 23, 2025.
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
zacks.com
2025-07-21 10:41:08Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
zacks.com
2025-07-17 10:41:43Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Growth Stocks to Buy for July 17th
zacks.com
2025-07-17 06:06:05QFIN, AFYA and PAHC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 17, 2025.
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC)
zacks.com
2025-07-16 13:46:17Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PAHC or BSX: Which Is the Better Value Stock Right Now?
zacks.com
2025-07-16 12:41:10Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results
businesswire.com
2025-08-20 16:00:00TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be availab.
PAHC vs. BSX: Which Stock Is the Better Value Option?
zacks.com
2025-08-20 12:41:23Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
zacks.com
2025-08-20 10:41:54Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run?
zacks.com
2025-08-20 10:16:03Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PAHC Stock Up 76.4% in a Year: What's Driving the Rally?
zacks.com
2025-08-20 09:55:28Phibro Animal Health's 76.4% stock surge is fueled by strong sales recovery, global growth and a robust balance sheet.
Phibro (PAHC) is an Incredible Growth Stock: 3 Reasons Why
zacks.com
2025-08-18 13:46:16Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
zacks.com
2025-08-04 12:41:24Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the better value opportunity right now?
3 Reasons Growth Investors Will Love Phibro (PAHC)
zacks.com
2025-08-01 13:46:18Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Phibro Animal Health Corporation Declares Quarterly Dividend
businesswire.com
2025-07-29 16:10:00TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on September 24, 2025, to stockholders of record at the close of business on September 3, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner.
Best Growth Stocks to Buy for July 23rd
zacks.com
2025-07-23 10:10:22PAHC, AFYA and ROAD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 23, 2025.
Best Value Stocks to Buy for July 23rd
zacks.com
2025-07-23 10:01:52NX, OPBK and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 23, 2025.
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
zacks.com
2025-07-21 10:41:08Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
zacks.com
2025-07-17 10:41:43Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Growth Stocks to Buy for July 17th
zacks.com
2025-07-17 06:06:05QFIN, AFYA and PAHC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 17, 2025.
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC)
zacks.com
2025-07-16 13:46:17Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
PAHC or BSX: Which Is the Better Value Stock Right Now?
zacks.com
2025-07-16 12:41:10Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?